TY - JOUR
T1 - Binding of glyceraldehyde-3-phosphate dehydrogenase to the cis-acting element of structure-anchored repression in ccn2 mRNA
AU - Kondo, Seiji
AU - Kubota, Satoshi
AU - Mukudai, Yoshiki
AU - Nishida, Takashi
AU - Yoshihama, Yasuto
AU - Shirota, Tatsuo
AU - Shintani, Satoru
AU - Takigawa, Masaharu
N1 - Funding Information:
This work was supported by the programs Grants-in-Aid for Scientific Research (S) [to M.T.] and (C) [to S.K.] from Japan Society for the Promotion of Science ; by Grants-in-Aid for Exploratory Research (to M.T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan ; by Grants-in-Aid for Fellows of the Japanese Society for the Promotion of Science (to S. Kondo); and by grants from the Sumitomo Foundation (to M.T.), Kurozumi Medical Foundation (to S.K.), and Foundation of Sanyo Broadcasting (to S.K.).
PY - 2011/2/18
Y1 - 2011/2/18
N2 - CCN2/connective tissue growth factor (CTGF) can be induced by hypoxia and promotes tumor angiogenesis. Our previous studies revealed that hypoxia-induced gene expression of human ccn2 mRNA is regulated post-transcriptionally in human chondrosarcoma-derived cell line, HCS-2/8, in which a minimal cis-element, entitled CAESAR, in the 3'-untranslated region (UTR) of ccn2 mRNA and a 35-kDa protein counterpart play an important role by determining the stability of ccn2 mRNA. In the present study, we identified this corresponding protein as glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by utilizing RNA affinity chromatography combined with mass spectrometry. The results of an RNA binding assay revealed the specific binding of GAPDH to this cis-element. To further characterize the interaction between GAPDH and ccn2 mRNA, we examined the roles of redox conditions and glycolytic coenzyme in the binding of GAPDH to the ccn2 mRNA. An oxidizing agent, diamide, abolished the GAPDH-RNA interaction in a concentration-dependent manner; whereas this effect could be reversed by subsequent treatment with 2-mercaptoethanol (2-ME). In addition, nicotinamide-adenine dinucleotide (NAD), a coenzyme of GAPDH, inhibited the GAPDH-RNA binding. Taken together, these findings suggest that the glycolytic enzyme GAPDH regulates the gene expression of ccn2 mRNA in trans by acting as a sensor of oxidative stress and redox signals, leading to CCN2 overexpression under the condition of hypoxia and promotion of angiogenesis.
AB - CCN2/connective tissue growth factor (CTGF) can be induced by hypoxia and promotes tumor angiogenesis. Our previous studies revealed that hypoxia-induced gene expression of human ccn2 mRNA is regulated post-transcriptionally in human chondrosarcoma-derived cell line, HCS-2/8, in which a minimal cis-element, entitled CAESAR, in the 3'-untranslated region (UTR) of ccn2 mRNA and a 35-kDa protein counterpart play an important role by determining the stability of ccn2 mRNA. In the present study, we identified this corresponding protein as glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by utilizing RNA affinity chromatography combined with mass spectrometry. The results of an RNA binding assay revealed the specific binding of GAPDH to this cis-element. To further characterize the interaction between GAPDH and ccn2 mRNA, we examined the roles of redox conditions and glycolytic coenzyme in the binding of GAPDH to the ccn2 mRNA. An oxidizing agent, diamide, abolished the GAPDH-RNA interaction in a concentration-dependent manner; whereas this effect could be reversed by subsequent treatment with 2-mercaptoethanol (2-ME). In addition, nicotinamide-adenine dinucleotide (NAD), a coenzyme of GAPDH, inhibited the GAPDH-RNA binding. Taken together, these findings suggest that the glycolytic enzyme GAPDH regulates the gene expression of ccn2 mRNA in trans by acting as a sensor of oxidative stress and redox signals, leading to CCN2 overexpression under the condition of hypoxia and promotion of angiogenesis.
KW - 3'-UTR
KW - CCN2
KW - GAPDH
KW - Hypoxia
KW - MRNA stability
UR - http://www.scopus.com/inward/record.url?scp=79951580936&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79951580936&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2011.01.034
DO - 10.1016/j.bbrc.2011.01.034
M3 - Article
C2 - 21236242
AN - SCOPUS:79951580936
VL - 405
SP - 382
EP - 387
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
SN - 0006-291X
IS - 3
ER -